Baidu
map

睡的多,高血压风险高!中国慢性病前瞻性研究分析

2022-07-27 中国循环杂志 中国循环杂志

研究还发现,睡眠时间与收缩压的关系比舒张压更密切。

高血压与年龄、遗传因素、环境因素和多种不良生活方式均有关,近日,中国慢性病前瞻性研究在中国西南地区的居民中调查发现,睡眠时间长与高血压有关。

本研究在四川省彭州市的15个乡镇纳入55 687名居民,年龄30~79岁。高血压患病率为25.17%。

男性和女性的高血压患病率均随年龄增长而增加。随着教育水平、家庭年收入和饮茶的增加,男女的高血压患病率均下降,随新鲜水果摄入量的减少、体重指数和睡眠打鼾频率增加而增加。

糖尿病患者的高血压患病率(48.98%)是非糖尿病患者(24.23%)的两倍。脑卒中患者中的高血压患病率(73.54%)几乎是非脑卒中患者(24.91%)的三倍。

睡眠时间<6、6、7、8和≥9 h/d的居民中,高血压患病率分别是21.74%, 17.56%, 19.17%, 28.00% 和13.53%,。

未经调整的分析表明,与7 h/d睡眠者相比,睡眠<6 h/d、6 h/d者患高血压风险分别增加47%和19%。

调整混杂因素后,睡眠时间≥9 h/d,高血压患病风险增加17%,睡眠时间短不再与高血压相关。

按性别分析,睡眠时间≥9 h/d,女性高血压患病风险增加19%,男性高血压患病风险增加16%。

研究发现,在睡眠时间达到6.81小时左右之前,患高血压患病风险相对平稳,超过该水平后开始迅速增加,呈J型关系。在女性中,睡眠时间与高血压呈U型关系。

研究还发现,睡眠时间与收缩压的关系比舒张压更密切。

研究的分层分析结果显示,在45~79岁的居民中,长时间睡眠与高血压风险升高有关。然而,在30~44岁的人群中没有发现这种相关性。而且在45~59岁的亚组中观察到J型关系。

此外,睡眠时间长与不经常食用新鲜水果的人的高血压患病率升高有关,而在经常食用新鲜水果的居民中则不然。

高血压患者睡眠时间长的机制尚不清楚,研究者分析可能与其他一些风险因素有关,如体力活动可能较少、睡眠障碍(睡眠呼吸暂停等)或睡眠质量差。其次还有因遗传、行为和环境因素导致的个体的睡眠需求不同。

河北省人民医院学者曾研究发现,睡眠时间与冠心病发病及死亡风险呈U型关系。睡眠时间<6.5 h/d是冠心病的危险因素,睡眠时间> 8.0 h/d及7.5 h/d增加冠心病发病及死亡风险。

来源:

[1]Association between sleep duration and hypertension in southwest China: a population-based cross-sectional study. BMJ Open. 2022 Jun 27;12(6):e052193.

[2] 张欣, 汪妍, 范聪, 等. 睡眠时间与冠心病发病及死亡风险前瞻性研究的Meta分析. 2021, 36(3): 258-365. DOI: 10.3969/j.issn.1000-3614.2021.03.006.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1914502, encodeId=e55c19145029d, content=<a href='/topic/show?id=103f3264681' target=_blank style='color:#2F92EE;'>#前瞻性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32646, encryptionId=103f3264681, topicName=前瞻性研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Mar 19 11:30:08 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006573, encodeId=aabd20065e340, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Sat Dec 31 10:30:08 CST 2022, time=2022-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264086, encodeId=52391264086e6, content=<a href='/topic/show?id=847353580bf' target=_blank style='color:#2F92EE;'>#慢性病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53580, encryptionId=847353580bf, topicName=慢性病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Fri Jul 29 01:30:08 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235140, encodeId=9551123514021, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Jul 27 20:16:02 CST 2022, time=2022-07-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1914502, encodeId=e55c19145029d, content=<a href='/topic/show?id=103f3264681' target=_blank style='color:#2F92EE;'>#前瞻性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32646, encryptionId=103f3264681, topicName=前瞻性研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Mar 19 11:30:08 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006573, encodeId=aabd20065e340, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Sat Dec 31 10:30:08 CST 2022, time=2022-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264086, encodeId=52391264086e6, content=<a href='/topic/show?id=847353580bf' target=_blank style='color:#2F92EE;'>#慢性病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53580, encryptionId=847353580bf, topicName=慢性病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Fri Jul 29 01:30:08 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235140, encodeId=9551123514021, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Jul 27 20:16:02 CST 2022, time=2022-07-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1914502, encodeId=e55c19145029d, content=<a href='/topic/show?id=103f3264681' target=_blank style='color:#2F92EE;'>#前瞻性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32646, encryptionId=103f3264681, topicName=前瞻性研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Mar 19 11:30:08 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006573, encodeId=aabd20065e340, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Sat Dec 31 10:30:08 CST 2022, time=2022-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264086, encodeId=52391264086e6, content=<a href='/topic/show?id=847353580bf' target=_blank style='color:#2F92EE;'>#慢性病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53580, encryptionId=847353580bf, topicName=慢性病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Fri Jul 29 01:30:08 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235140, encodeId=9551123514021, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Jul 27 20:16:02 CST 2022, time=2022-07-27, status=1, ipAttribution=)]
    2022-07-29 qjddjq
  4. [GetPortalCommentsPageByObjectIdResponse(id=1914502, encodeId=e55c19145029d, content=<a href='/topic/show?id=103f3264681' target=_blank style='color:#2F92EE;'>#前瞻性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32646, encryptionId=103f3264681, topicName=前瞻性研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Mar 19 11:30:08 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006573, encodeId=aabd20065e340, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Sat Dec 31 10:30:08 CST 2022, time=2022-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264086, encodeId=52391264086e6, content=<a href='/topic/show?id=847353580bf' target=_blank style='color:#2F92EE;'>#慢性病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53580, encryptionId=847353580bf, topicName=慢性病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Fri Jul 29 01:30:08 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235140, encodeId=9551123514021, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Jul 27 20:16:02 CST 2022, time=2022-07-27, status=1, ipAttribution=)]
    2022-07-27 yangchou

    好文章,谢谢分享。

    0

相关资讯

吃,睡,玩:全国代表性样本中癌症幸存者的健康行为及其与心理健康的关系

BMC Cancer:满足个人和多种健康行为的指导方针与癌症幸存者的良好心理健康有关

Science:董海龙团队等揭示压力会诱导睡眠,从而减轻焦虑

提到压力,工作上的也好,生活上的也好,我们通常想到的是这些压力会导致失眠,但实际上,有些压力反而会促进睡眠。近日,英国帝国理工学院和第四军医大学的研究团队合作,揭示了压力是如何促进睡眠的。

Nature重磅发现:人睡着时,肿瘤苏醒,癌细胞在睡眠期间加速分裂和转移扩散

乳腺癌是肿瘤中预后较好的类型,如果及早发现,患者通常对治疗反应良好。然而,乳腺癌易发生转移,当循环中的癌细胞脱离原肿瘤,并通过血管在体内传播到其他器官或阻止形成新的肿瘤,就发生了癌症转移。

Nature子刊揭示:青少年时期睡眠不足,或将引发成年后社恐!

睡眠是人体的基本需求,但大部分人对睡眠的认识,远远不够。良好的睡眠不仅有助于学习和记忆等认知功能,更是影响机体新陈代谢的重要因素。

熬夜后,白天补觉,并不能减轻熬夜带来的伤害

熬夜很爽,但是一直熬夜一直......

27万亚洲人研究:这样睡觉,更容易得癌!

Int J Cancer:睡眠持续时间与癌症发病和死亡风险的关联:对日本六个基于人群的队列的汇总分析

Baidu
map
Baidu
map
Baidu
map